CLINICAL_TRIALS
trial_result
· 2010-08-18
Clinical Trial Update: A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease [Phase 4]
Summary
Phase 4 trial evaluating the safety and efficacy of Fabrazyme in patients with Fabry disease; results were posted in 2010.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Genzyme, a Sanofi Company | Conditions: Fabry Disease | Phase 4 | Status: COMPLETED | Results posted: 2010-08-18